New shot aims to zap bad cholesterol
NCT ID NCT07473960
Summary
This study is testing a new injectable drug called IBI306 to see if it safely lowers 'bad' LDL cholesterol in adults with high cholesterol and mixed lipid levels. About 198 participants will be randomly assigned to receive either the real drug or a placebo (dummy) injection for 12 weeks. The main goal is to measure how much the drug reduces LDL cholesterol compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-FAMILIAL HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100083, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.